ConductScience.org, home

Trial · NCT05495620

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

NCT05495620, Unknown, Dong-A University Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Long-term KRd in Relapsed and/or Refractory Multiple Myeloma. Trials, record NCT05495620. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05495620

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Long-term KRd in Relapsed and/or Refractory Multiple Myeloma
NCT number
NCT05495620
Status
Unknown
Enrollment
300 participants, estimated
Lead sponsor
Dong-A University Hospital
Conditions
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Interventions
Carfilzomib, Lenalidomide, Dexamethasone
First posted
2022-08-10
Last updated
2022-08-10

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryProgression-free survivalup to 54 monthsthe time from the first date of KRd to the date of disease progression or death or censored date
SecondaryOverall survivalup to 54 monthsthe time from the first date of KRd treatment to the time of death or censored date
SecondaryOverall response rate, clinical benefit rateup to 54 monthsthe proportion of patients who achieved a PR or better, which response is defined by the IMWG criteria, the proportion of patients who achieved a MR or better
SecondaryDuration of responseup to 54 monthsthe time from the first date of response to the time of disease progression or death or censored date
SecondaryToxicity profileup to 2 yearstoxicities as determined by the incidence of clinical and laboratory findings occurred from the time of the first date of KRd treatment to the date of disease progression or death or censored date

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
25482145BACKGROUND

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05495620

GET https://conductscience.org/api/trials/v1/NCT05495620/registered